Picture of IRLAB Therapeutics AB logo

IRLAB A — IRLAB Therapeutics AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Brief: IRLAB Changes CEO, Appoints New Chairman

Feb 21 (Reuters) - IRLAB Therapeutics AB  IRLABa.ST :
    * ANNOUNCED ON MONDAY THAT CEO RICHARD GODFREY IS LEAVING
HIS
POSITION
    * BOD HAS APPOINTED GUNNAR OLSSON, CURRENT CHAIRMAN, AS
INTERIM
CEO
    * GUNNAR OLSSON WILL NOW TRANSITION TO POSITION AS BOARD
DIRECTOR
    * BOD HAS APPOINTED CO'S CURRENT VICE CHAIRMAN, CAROLA
LEMNE, AS
ITS NEW CHAIRMAN
    * ALL CHANGES WILL BE IMPLEMENTED IMMEDIATELY, PROCESS TO
RECRUIT
PERMANENT CEO WILL START IMMEDIATELY

        
 Source text for Eikon:  urn:newsml:reuters.com:*:nACS6LyVka
 Further company coverage:  IRLABa.ST  
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on IRLAB Therapeutics AB

See all news